Triple negative breast cancer accounts for approximately 10-20% of breast cancers and is characterized by the lack -or by very low - expression of oestrogen and progesterone receptors and the lack of amplification of the gene coding for HER2 (Human Epidermal Growth Factor Receptor 2) (1). Here, ERBB2 is linked to triple-negative breast carcinoma.